2 days ago · Explore BioTechniques. A world leader in life science method research news. ISSN (print): 0736-6205 | ISSN (online): 1940-9818.

Jan 9, 2025 · 2024 marked a year of great progress for BioTechniques following our acquisition by Taylor & Francis (Oxford, UK) as we worked to develop new and exciting features to bring you information from the vast swathe of journals now at our disposal while continuing to produce the content that our readers know and love.

Sep 13, 2024 · The Ig Nobel Prizes find the fun in science, awarding those research endeavors that comically contribute to our understanding of the world in areas such as botany, medicine, biology and chemistry. From discovering that mammals are capable of breathing through their anus to the way peoples’ hair swirls depending on which hemisphere they’re from, this year’s winning research certainly ...

Jan 29, 2025 · Partnerships and publications UK Biocentre partners with Azenta Life Sciences to expand sample storage for biomedical research. Azenta, Inc. (MA, USA) announced that it has been selected as the technology provider by UK Biocentre (Milton Keynes, UK) as they expand their large-scale sample storage in support of the preservation of …

Jan 28, 2025 · A great deal has changed since April 2003 when the human genome was first sequenced. Now, Enhanced Genomics (Cambridge, UK) has developed a 3D multi-omic profiling technology, GenLink, that combines molecular and computational techniques to enhance decision making at all stages of the drug discovery and development process.

Oct 31, 2024 · Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Sep 20, 2024 · Findings revealed that elevated levels of sNfL were associated with a 45% increased risk of RAW and a 43% increased risk of PIRA. The researchers found that patients with elevated sNfL did not respond well to standard disease-modifying therapies (DMTs) but showed improvements when treated with high-efficacy DMTs, including immunotherapies such as natalizumab and ocrelizumab.

Nov 13, 2024 · In this interview, Tong Huo discusses the current landscape of CAR-T therapies and the future of CAR-T, including next-generation approaches, gene-editing innovations and applications beyond oncology.

Feb 4, 2025 · Speakers. Silvia Crescioli. Business Intelligence Creator. The Antibody Society, Inc. Dr. Silvia Crescioli is a Consultant for The Antibody Society. Since 2021 she has co-authored the “Antibodies to watch” articles in published in mAbs. Dr. Crescioli received her PhD in Biomedical Sciences, Experimental Oncology, from the University of Florence in 2014, then held a …

Nov 20, 2024 · Publications and partnerships Extracellular vesicles (EVs) at the core of European consortium. Mursla Bio (Cambridge, UK), has joined EVEREST, a European consortium funded by Horizon Europe (Tbilisi, Georgia) and set up to advance EV research, innovation and clinical translation for the benefit of patients. Mursla has been selected to help support scaling and commercialization strategy for EV ...